Sign In

Carter Caldwell

Penn Medicine Co-Investment Program Director, University of Pennsylvania Health System

Carter Caldwell is a seasoned professional serving as the Penn Medicine Co-Investment Program Director, overseeing investments in various sectors like cell therapy, gene therapy, mRNA, lipid nanoparticles, and connected health.

With a background encompassing venture capital, private equity, and entrepreneurship, Carter contributes his expertise in sourcing investments, conducting due diligence, managing investor relations, and supporting funded companies' governance.

Having delved into Healthcare IT, SaaS, Enterprise Software, AI, and Fintech industries, among others, Carter has been instrumental in spearheading new investment initiatives during his tenure as a Managing Director at Cross Atlantic Capital Partners.

His tech-savvy nature is evident from having founded and led two software companies. Notably, he was the COO of Quazant Technology, known for developing the Transaction Accelerator® used across various industries. Prior to this, Carter played key roles at Acorn Systems, an acquired software company.

A well-known figure in the industry, Carter has authored publications, lectured at Villanova Law School, and spoken at numerous industry events. Additionally, he has contributed his expertise as a judge in various competitions like the Wharton Business Plan Competition and the Ernst & Young Entrepreneur of the Year Competition.

Carter Caldwell is an alumnus of Columbia University, holding an MBA, and the University of Pennsylvania, where he earned a BA in Philosophy, Politics, and Economics.

Carter Caldwell
Add to my network

Location

Philadelphia, Pennsylvania, United States